Artivion, Inc. (AORT) is a Healthcare stock trading at $21.18 (as of 2026-06-18), with a market capitalization of $999.02M and a trailing P/E of 80.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues for procedures in areas including cardiac, vascular, neurologic, and pulmonary care. Its offerings include products such as BioGlue and PhotoFix, preservation and related services, stent graft systems for aortic and peripheral vascular disease, and synthetic vascular grafts used in open aortic and peripheral surgeries.